French Business Law - French Legislation

Article L4443-4 of the French Public Health Code

November 7, 2023

The Disciplinary Board may only rule when all its members and its Chairman are present. If the quorum is not reached, the Chairman shall (1) reconvene the members of the Disciplinary Board, which shall then sit validly regardless of the number of members present. In the event of a tie, the Chairman shall have the casting vote. Practitioners called to appear before the Disciplinary Board may be assisted by a…

Article L4443-4-1 of the French Public Health Code

November 7, 2023

A case may be referred to the Disciplinary Chamber by the President of the Government of New Caledonia or French Polynesia, the Public Prosecutor, the State representative, the President of the National Council, the President of the Association body of New Caledonia or French Polynesia, a pharmacist entered on the roll of the Association or, under conditions determined by decree, a private individual in the event of a breach of…

Article L4443-5 of the French Public Health Code

November 7, 2023

Penalties and bans imposed in application of article L. 4234-6 that have become final are brought to the attention of the disciplinary chamber of the pharmacists’ association of New Caledonia and French Polynesia by the national council of the association.

Article L4443-6 of the French Public Health Code

November 7, 2023

For its application in New Caledonia and French Polynesia, the following is added to article L. 4231-4: “An agreement between the Conseil national de l’ordre and the professional body of New Caledonia on the one hand, and that of French Polynesia on the other hand, sets out the terms of coordination between these two institutions.”

Article L4444-1 of the French Public Health Code

November 7, 2023

Subject to the adaptations provided for in the following paragraphs, the provisions of Article L. 4011-5 are applicable in New Caledonia and French Polynesia in the wording resulting from Law No. 2019-774 of 24 July 2019 on the organisation and transformation of the healthcare system. For the application in New Caledonia and French Polynesia of Article L. 4011-5, the authorisation by the Minister for Defence of cooperation protocols within the…

Article L4444-2 of the French Public Health Code

November 7, 2023

Subject to the adaptations provided for in the second paragraph, Articles L. 4061-1 to L. 4061-7 shall apply in New Caledonia and French Polynesia in the version resulting from Order No. 2018-20 of 17 January 2018 17 January 2018. For the application in New Caledonia and French Polynesia of Article L. 4061-4 in New Caledonia and French Polynesia: 1° The words: “the regional health agencies”, “the regional health agency” and…

Article L4444-3 of the French Public Health Code

November 7, 2023

The provisions of articles L. 4131-2, L. 4141-4, L. 4151-6, L. 4221-15, L. 4241-10, L. 4311-12-1 and L. 4321-7 are applicable in New Caledonia and French Polynesia in their wording resulting from Order no. 2018-20 of 17 January 2018, insofar as they concern students carrying out an activity as part of a commitment to serve in the operational reserve provided for in article L. 4211-1 of the Defence Code.

Article L5111-1 of the French Public Health Code

November 7, 2023

I.- Medicinal product for human use means any substance or combination of substances presented as having properties for treating or preventing disease in human beings, as well as any substance or combination of substances which may be used in human beings or which may be administered to human beings with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions by exerting a pharmacological, immunological…

Article L5111-2 of the French Public Health Code

November 7, 2023

A pharmaceutical speciality is any medicine prepared in advance, packaged in a particular container and identified by a special name.

Article L5111-3 of the French Public Health Code

November 7, 2023

Falsified medicinal product means any medicinal product, as defined in Article L. 5111-1, involving a misrepresentation of: 1° Its identity, including its packaging and labelling, its name or its composition with regard to any of its constituents, including excipients, and the dosage of these constituents; 2° Its source, including its manufacturer, country of manufacture, country of origin or marketing authorisation holder; 3° Or its history, including authorisations, registrations and documents…

Call Us + 33 1 84 88 31 00

Call Us + 33 1 84 88 31 00

French Public Health Code

Article L4443-4 of the French Public Health Code

Article L4443-4-1 of the French Public Health Code

Article L4443-5 of the French Public Health Code

Article L4443-6 of the French Public Health Code

Article L4444-1 of the French Public Health Code

Article L4444-2 of the French Public Health Code

Article L4444-3 of the French Public Health Code

Article L5111-1 of the French Public Health Code

Article L5111-2 of the French Public Health Code

Article L5111-3 of the French Public Health Code

Contact a French lawyer now

Contact a French Business Lawyer

Do you need French-law advice?
Contact our Lawyers in France.

Call + 33 1 84 88 31 00.

Our attorneys will contact you promptly within 24h. All information exchanged through this website will be communicated to attorneys only, and will remain confidential.

We Solve Legal & Tax Issues in France

French Public Health Code

Contact a French lawyer now

Contact a French Business Lawyer

Do you need French-law advice? Contact our Lawyers in France.

Our attorneys will contact you promptly within 24h. All information exchanged through this website will be communicated to attorneys only, and will remain confidential.

We Solve Legal & Tax Issues in France

Useful links

You have a question in French Business Law?

Do you need French-law advice?
Contact our Lawyers in France.